Pacific Biosciences
PACB
PACB
174 hedge funds and large institutions have $1.45B invested in Pacific Biosciences in 2020 Q3 according to their latest regulatory filings, with 52 funds opening new positions, 62 increasing their positions, 41 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
51% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 41
15% more funds holding
Funds holding: 151 → 174 (+23)
13.63% more ownership
Funds ownership: 70.5% → 84.13% (+14%)
Holders
174
Holding in Top 10
5
Calls
$6.31M
Puts
$751K
Top Buyers
| 1 | +$115M | |
| 2 | +$44.6M | |
| 3 | +$44.4M | |
| 4 |
NAMA
Nikko Asset Management Americas
New York
|
+$41.2M |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$40.6M |
Top Sellers
| 1 | -$44M | |
| 2 | -$38.4M | |
| 3 | -$33M | |
| 4 |
GF
Gabelli Funds
Rye,
New York
|
-$20.4M |
| 5 |
GCM
Glenview Capital Management
New York
|
-$10.9M |